Seeking Alpha

Parexel (PRXL) plummeted 18% AH after it reported FQ3 earnings below estimates and cut its...

Parexel (PRXL) plummeted 18% AH after it reported FQ3 earnings below estimates and cut its profit and revenue forecasts for fiscal 2011. EPS was +23% to $0.26 and revenue +3% to $301.4M. The pharma research firm plans to restructure in response. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)